Andera Partners has led a $55m funding round for Dynacure, co-founded by Satt Conectus to commercialise research from the Institute of Genetic and Molecular and Cellular Biology.
Dynacure, a France-based biotechnology spinout from the Institute of Genetic and Molecular and Cellular Biology, raised €47m ($55m) in funding yesterday from investors led by Andera Partners.
French government-owned investment bank Bpifrance also took part in the round, as did Pontifax, Kurma Partners and IdInvest Partners.
Founded in 2016, Dynacure is working on Dyn101, a treatment for centronuclear myopathy, a group of rare and often fatal conditions that cause muscle weakness and wasting. Dyn101 is being developed in collaboration with…
